Shock absorber maker Taylor Devices' Q1 sales fall

By Reuters News


Overview

  • US shock absorption device maker's fiscal Q1 sales fell 26% yr/yr

  • Fiscal Q1 net earnings declined sharply from prior year

  • Lower sales due to late-arriving backlog delaying revenue recognition


Outlook

  • Company says it will continue investments in team, R&D and facilities in FY27


Result Drivers

  • LOWER SALES VOLUME - Co said late-arriving backlog in prior fiscal year pushed associated sales recognition out of Q1, reducing sales and profitability

  • PRODUCT MIX & DEVELOPMENT - Co said product sales mix and new product development efforts further pressured margins in Q1

  • MARKET CONDITIONS - Co said structural markets faced headwinds from higher interest rates and FX, while aerospace/defense benefited from global unrest


Company press release:


Key Details

Metric

Beat/Miss

Actual

Consensus Estimate

Q1 Sales

Miss

$7.30 mln

$13.10 mln (1 Analyst)

Q1 EPS

$0.14


Analyst Coverage

  • The one available analyst rating on the shares is "buy"

  • The average consensus recommendation for the industrial machinery & equipment peer group is "buy"

  • Wall Street's median 12-month price target for Taylor Devices Inc is $70.00, about 14.5% above its October 1 closing price of $61.11

  • The stock recently traded at 15 times the next 12-month earnings vs. a P/E of 15 three months ago


Reuters Recommended Reads

  • Sept 30 - No doubt that consumer is under pressure, says Conagra CEO

  • Sept 30 - Chinese factory activity expands in September amid AI boom


For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.


(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk